Literature DB >> 12663931

Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease.

Martin H Deininger1, Kubrom Bekure-Nemariam, Katrin Trautmann, Matthias Morgalla, Richard Meyermann, Hermann J Schluesener.   

Abstract

Cyclooxygenases (COXs) mediate inflammation, immunomodulation, blood flow, apoptosis, and fever in various diseases of the brain. Whereas COX-2 is cytokine inducible, COX-1 is expressed by macrophages/microglial cells that accumulate in pathological foci. We analyzed the localization of COX-1 and COX-2 in postmortem cortex slices of eight patients who died with sporadic Creutzfeldt-Jakob disease (CJD) and four neuropathologically unaltered controls by immunohistochemical double-labeling, reverse transcriptase polymerase chain reaction (RT-PCR), and Western blotting experiments. In healthy brains, COX-1 was expressed by single macrophages/microglial cells and COX-2 by disseminated neurons. In patients with CJD, significantly (p = 0.0195) more COX-1-expressing macrophages/microglial cells were detected adjacent to neurons. COX-2 expression was predominantly observed in neurons, and their number was significantly higher (p < 0.0001) compared to controls. RT-PCR and Western blotting revealed more COX-1 and COX-2 mRNA and protein in one CJD patient than in one control patient. These data show that accumulation of COX-1-expressing macrophages/microglial cells and COX-2-expressing neurons might represent important regulatory mechanisms in the complex process of neuronal degeneration in CJD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663931     DOI: 10.1385/JMN:20:1:25

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  19 in total

1.  Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition.

Authors:  R D Simmons; A R Hugh; D O Willenborg; W B Cowden
Journal:  Acta Neurol Scand       Date:  1992-03       Impact factor: 3.209

2.  Cyclooxygenase-2 in the spinal cord: localization and regulation after a peripheral inflammatory stimulus.

Authors:  M Goppelt-Struebe; F Beiche
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

3.  Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases.

Authors:  M Guentchev; J Wanschitz; T Voigtländer; H Flicker; H Budka
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.

Authors:  B Samuelsson
Journal:  Acta Biol Med Ger       Date:  1976

5.  Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain.

Authors:  S Lacroix; S Rivest
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

6.  Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo.

Authors:  M H Deininger; M Weller; J Streffer; M Mittelbronn; R Meyermann
Journal:  Acta Neuropathol       Date:  1999-09       Impact factor: 17.088

7.  HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxygenase type 2 (COX-2).

Authors:  G Bagetta; M T Corasaniti; A M Paoletti; L Berliocchi; R Nisticò; A M Giammarioli; W Malorni; A Finazzi-Agrò
Journal:  Biochem Biophys Res Commun       Date:  1998-03-27       Impact factor: 3.575

8.  Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.

Authors:  M Nakayama; K Uchimura; R L Zhu; T Nagayama; M E Rose; R A Stetler; P C Isakson; J Chen; S H Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Brain kininogen following experimental brain injury: evidence for a secondary event.

Authors:  E F Ellis; J Chao; M L Heizer
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

10.  Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.

Authors:  S Nogawa; F Zhang; M E Ross; C Iadecola
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

View more
  10 in total

Review 1.  The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.

Authors:  Sang-Ho Choi; Saba Aid; Francesca Bosetti
Journal:  Trends Pharmacol Sci       Date:  2009-03-09       Impact factor: 14.819

2.  Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE).

Authors:  Samir S Ayoub; Elizabeth G Wood; Sabih-Ul Hassan; Christopher Bolton
Journal:  Inflamm Res       Date:  2011-06-12       Impact factor: 4.575

3.  Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever.

Authors:  S A Appel; J Chapman; E Kahana; H Rosenmann; I Prohovnik; E Pras; H Reznik-Wolf; O S Cohen
Journal:  Eur J Neurol       Date:  2010-01-20       Impact factor: 6.089

4.  Immunohistochemical increase in cyclooxygenase-2 without apoptosis in different brain areas of subchronic nicotine- and D-amphetamine-treated rats.

Authors:  A Toledano; M I Alvarez; I Caballero; P Carmona; E De Miguel
Journal:  J Neural Transm (Vienna)       Date:  2008-03-20       Impact factor: 3.575

Review 5.  Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System.

Authors:  Tatsurou Yagami; Hiromi Koma; Yasuhiro Yamamoto
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

Review 6.  Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?

Authors:  Colm Cunningham; Donal Thomas Skelly
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-20       Impact factor: 4.147

7.  Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease.

Authors:  Franc Llorens; Irene López-González; Katrin Thüne; Margarita Carmona; Saima Zafar; Olivier Andréoletti; Inga Zerr; Isidre Ferrer
Journal:  Front Aging Neurosci       Date:  2014-08-04       Impact factor: 5.750

Review 8.  The Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity.

Authors:  Juliane Obst; Emilie Simon; Renzo Mancuso; Diego Gomez-Nicola
Journal:  Front Aging Neurosci       Date:  2017-06-23       Impact factor: 5.750

9.  A systems approach to prion disease.

Authors:  Daehee Hwang; Inyoul Y Lee; Hyuntae Yoo; Nils Gehlenborg; Ji-Hoon Cho; Brianne Petritis; David Baxter; Rose Pitstick; Rebecca Young; Doug Spicer; Nathan D Price; John G Hohmann; Stephen J Dearmond; George A Carlson; Leroy E Hood
Journal:  Mol Syst Biol       Date:  2009-03-24       Impact factor: 11.429

Review 10.  Is cyclooxygenase-1 involved in neuroinflammation?

Authors:  Nafiseh Ghazanfari; Aren van Waarde; Rudi A J O Dierckx; Janine Doorduin; Erik F J de Vries
Journal:  J Neurosci Res       Date:  2021-08-04       Impact factor: 4.433

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.